A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome

Mahesh Swaminathan, Hagop M. Kantarjian, Mark Levis, Veronica Guerra, Gautam Borthakur, Yesid Alvarado, Courtney D. DiNardo, Tapan Kadia, Guillermo Garcia-Manero, Maro Ohanian, Naval Daver, Marina Konopleva, Naveen Pemmaraju, Alessandra Ferrajol, Michael Andreeff, Nitin Jain, Zeev Estrov, Elias J. Jabbour, William G. Wierda, Sherry PierceMaria Rhona Pinsoy, Lianchun Xiao, Farhad Ravandi, Jorge E. Cortes

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences